Symptoms and adverse effects with chemotherapy±bevacizumab for platinum-resistant recurrent ovarian cancer: Analysis of the phase III AURELIA trial

✍ Scribed by Hilpert, F.; Fabbro, M.; Rubio, M. Jesus; Reuss, A.; Rosenberg, P.; Panici, P. Benedetti; Vuylsteke, P.; Witteveen, P.; Zagouri, F.; Pujade-Lauraine, E.

• Book ID: 121474530
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 60 KB
• Volume: 130
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2013.04.063